stockrowLegend Biotech Corporation Sponsored ADR
LEGN Healthcare Biotechnology
Legend Biotech Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 64.0% from fiscal 2024.
- Revenue
- +51.9%
- EPS
- +126.1%
- Free cash flow
- −26.8%
- Total debt
- −49.6%
Quarter to June 2026, against a year earlier
Follow LEGN
Alert me
Legend Biotech Corporation Sponsored ADR (LEGN) Operating margin
Legend Biotech Corporation Sponsored ADR's operating margin over the twelve months to 30 June 2026 was −5.06%, up 24.2 percentage points from fiscal 2025 (−29.3%). Over the past ten years it has ranged from −581.3% (fiscal 2021) to 116.8% (fiscal 2017); the current reading is higher than 78% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −29.3% | 2.24 |
| FY2024 | −31.5% | 113.17 |
| FY2023 | −144.7% | 244.89 |
| FY2022 | −389.6% | 191.74 |
| FY2021 | −581.3% | (308.16) |
| FY2020 | −273.2% | (71.03) |
| FY2019 | −202.1% | (199.70) |
| FY2018 | −2.43% | (119.25) |
| FY2017 | 116.8% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 14.4% | 32.36 |
| Mar 2026 | −18.0% | (10.81) |
| Dec 2025 | −7.18% | 8.65 |
| Sep 2025 | −15.8% | 35.13 |
| 23 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ARQT Arcutis Biotherapeutics, Inc. compare | 6.91% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| TNGX Tango Therapeutics, Inc. compare | 0.00% |
| DFTX Definium Therapeutics, Inc. compare | 0.00% |
| LEGN Legend Biotech Corporation Sponsored ADR | −5.06% |
| IOVA Iovance Biotherapeutics, Inc. compare | −60.8% |
| ABCL AbCellera Biologics Inc. compare | −340.3% |
| RLAY Relay Therapeutics, Inc. compare | −2,815.5% |
| DNTH Dianthus Therapeutics, Inc. compare | −8,683.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on LEGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement